3-hydroxy-3'-N-acetylholyrine A
| Internal ID | 64f29ed3-cd1c-4770-9c65-925ed98603cd |
| Taxonomy | Organoheterocyclic compounds > Indoles and derivatives > Carbazoles > Pyrrolocarbazoles > Indolocarbazoles |
| IUPAC Name | N-[(2S,3R,4R,6R)-3-hydroxy-6-(7-hydroxy-12-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17,19,21-nonaen-3-yl)-2-methyloxan-4-yl]acetamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C28H26N4O5/c1-12-27(35)19(30-13(2)33)10-21(37-12)32-20-8-7-14(34)9-16(20)23-24-17(11-29-28(24)36)22-15-5-3-4-6-18(15)31-25(22)26(23)32/h3-9,12,19,21,27,31,34-35H,10-11H2,1-2H3,(H,29,36)(H,30,33)/t12-,19+,21+,27-/m0/s1 |
| InChI Key | YOELNZYRZIJSGB-FIHZCICZSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C28H26N4O5 |
| Molecular Weight | 498.50 g/mol |
| Exact Mass | 498.19031994 g/mol |
| Topological Polar Surface Area (TPSA) | 129.00 Ų |
| XlogP | 2.50 |
| Atomic LogP (AlogP) | 3.55 |
| H-Bond Acceptor | 6 |
| H-Bond Donor | 5 |
| Rotatable Bonds | 2 |
| 3-hydroxy-3'-N-acetylholyrine A |
| BDBM50465333 |
| PD134700 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6608 | 66.08% |
| Caco-2 | - | 0.8602 | 86.02% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.7429 | 74.29% |
| Subcellular localzation | Nucleus | 0.4414 | 44.14% |
| OATP2B1 inhibitior | - | 0.7158 | 71.58% |
| OATP1B1 inhibitior | + | 0.8254 | 82.54% |
| OATP1B3 inhibitior | + | 0.9378 | 93.78% |
| MATE1 inhibitior | - | 0.7809 | 78.09% |
| OCT2 inhibitior | - | 0.8956 | 89.56% |
| BSEP inhibitior | + | 0.9488 | 94.88% |
| P-glycoprotein inhibitior | + | 0.7480 | 74.80% |
| P-glycoprotein substrate | + | 0.8155 | 81.55% |
| CYP3A4 substrate | + | 0.6931 | 69.31% |
| CYP2C9 substrate | - | 0.8024 | 80.24% |
| CYP2D6 substrate | - | 0.8424 | 84.24% |
| CYP3A4 inhibition | - | 0.9332 | 93.32% |
| CYP2C9 inhibition | - | 0.6666 | 66.66% |
| CYP2C19 inhibition | - | 0.8301 | 83.01% |
| CYP2D6 inhibition | - | 0.8877 | 88.77% |
| CYP1A2 inhibition | - | 0.8843 | 88.43% |
| CYP2C8 inhibition | + | 0.7554 | 75.54% |
| CYP inhibitory promiscuity | - | 0.8072 | 80.72% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.5841 | 58.41% |
| Eye corrosion | - | 0.9908 | 99.08% |
| Eye irritation | - | 0.9788 | 97.88% |
| Skin irritation | - | 0.8084 | 80.84% |
| Skin corrosion | - | 0.9447 | 94.47% |
| Ames mutagenesis | + | 0.6600 | 66.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3969 | 39.69% |
| Micronuclear | + | 0.8800 | 88.00% |
| Hepatotoxicity | + | 0.6125 | 61.25% |
| skin sensitisation | - | 0.8968 | 89.68% |
| Respiratory toxicity | + | 0.8111 | 81.11% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.8625 | 86.25% |
| Nephrotoxicity | - | 0.7933 | 79.33% |
| Acute Oral Toxicity (c) | III | 0.6260 | 62.60% |
| Estrogen receptor binding | + | 0.7460 | 74.60% |
| Androgen receptor binding | + | 0.7121 | 71.21% |
| Thyroid receptor binding | + | 0.5437 | 54.37% |
| Glucocorticoid receptor binding | + | 0.7489 | 74.89% |
| Aromatase binding | - | 0.5355 | 53.55% |
| PPAR gamma | + | 0.7256 | 72.56% |
| Honey bee toxicity | - | 0.7743 | 77.43% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | - | 0.5300 | 53.00% |
| Fish aquatic toxicity | - | 0.4543 | 45.43% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| CHEMBL299 | P17252 | Protein kinase C alpha |
460 nM |
IC50 |
via Super-PRED
|
| CHEMBL2973 | O75116 | Rho-associated protein kinase 2 |
40 nM |
IC50 |
via Super-PRED
|
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.64% | 91.11% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 99.17% | 89.00% |
| CHEMBL2581 | P07339 | Cathepsin D | 98.75% | 98.95% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.65% | 85.14% |
| CHEMBL2708 | Q16584 | Mitogen-activated protein kinase kinase kinase 11 | 98.61% | 81.14% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.05% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.61% | 94.45% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 95.23% | 87.16% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 94.85% | 83.10% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 94.74% | 95.64% |
| CHEMBL2041 | P07949 | Tyrosine-protein kinase receptor RET | 94.60% | 91.79% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 94.54% | 85.11% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 94.49% | 95.56% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 93.96% | 98.59% |
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 93.54% | 97.03% |
| CHEMBL2095226 | P05556 | Integrin alpha-5/beta-1 | 93.39% | 96.39% |
| CHEMBL4924 | Q9UK32 | Ribosomal protein S6 kinase alpha 6 | 93.38% | 80.00% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 92.07% | 80.71% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 91.50% | 99.23% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.38% | 93.10% |
| CHEMBL2535 | P11166 | Glucose transporter | 89.72% | 98.75% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 88.92% | 92.67% |
| CHEMBL2716 | Q8WUI4 | Histone deacetylase 7 | 88.47% | 89.44% |
| CHEMBL5678 | P34947 | G protein-coupled receptor kinase 5 | 88.12% | 88.00% |
| CHEMBL3192 | Q9BY41 | Histone deacetylase 8 | 88.08% | 93.99% |
| CHEMBL2964 | P36507 | Dual specificity mitogen-activated protein kinase kinase 2 | 87.33% | 80.00% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 86.87% | 94.73% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 86.80% | 91.38% |
| CHEMBL3788 | O00444 | Serine/threonine-protein kinase PLK4 | 86.30% | 83.65% |
| CHEMBL2094127 | P06493 | Cyclin-dependent kinase 1/cyclin B | 85.62% | 96.00% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 85.54% | 90.08% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 85.12% | 93.03% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 84.74% | 91.49% |
| CHEMBL4225 | P49760 | Dual specificity protein kinase CLK2 | 83.71% | 80.96% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 83.13% | 94.00% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 83.04% | 90.00% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 82.03% | 86.33% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 81.95% | 97.00% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.64% | 88.56% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 80.92% | 97.09% |
| CHEMBL279 | P35968 | Vascular endothelial growth factor receptor 2 | 80.81% | 95.52% |
| CHEMBL4481 | P35228 | Nitric oxide synthase, inducible | 80.72% | 94.80% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 80.63% | 95.89% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139589941 |
| LOTUS | LTS0132377 |
| wikiData | Q105203971 |